90 Participants NeededMy employer runs this trial

Exendin 9-39 for Gestational Diabetes

Age: 18 - 65
Sex: Female
Trial Phase: Phase 1
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.

Who Is on the Research Team?

AE

Aoife Egan, MB, BCh, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for pregnant women who have been diagnosed with gestational diabetes. Specific inclusion and exclusion criteria are not listed, but generally participants should be otherwise healthy and able to safely participate in research during pregnancy.

Inclusion Criteria

Pregnant individuals with a viable singleton pregnancy who have completed second trimester gestational diabetes screening and are eligible for classification as either gestational diabetes mellitus or no gestational diabetes mellitus
Participants must be willing and able to provide informed consent and complete planned pregnancy and postpartum study visits

Exclusion Criteria

Fasting glucose ≥ 100 mg/dL or HbA1c ≥ 5.7% in early pregnancy
One abnormal value on the 3-hour 100 g oral glucose tolerance test
Glucose at least 190 mg/dL on glucose challenge testing without subsequent 3-hour oral glucose tolerance testing
See 7 more

What Are the Treatments Tested in This Trial?

Interventions

  • Exendin 9-39

Trial Overview

The study is testing a drug called Exendin 9-39 to see how it affects the pancreas' ability to make insulin during and after pregnancy in women with gestational diabetes.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Women Without Gestational Diabetes MellitusExperimental Treatment1 Intervention
Group II: Women With Gestational Diabetes MellitusExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+